| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.CCR.2007.10.028 |
| P8608 | Fatcat ID | release_5vrydjcc4fdz7kk2hjm222hjqy |
| P698 | PubMed publication ID | 17996645 |
| P5875 | ResearchGate publication ID | 5849570 |
| P2093 | author name string | Heiko Hermeking | |
| P433 | issue | 5 | |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 414-418 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Cancer Cell | Q280018 |
| P1476 | title | p53 enters the microRNA world | |
| P478 | volume | 12 |
| Q58776119 | A comprehensive investigation using meta-analysis and bioinformatics on miR-34a-5p expression and its potential role in head and neck squamous cell carcinoma |
| Q41758245 | A functional variant at miR-34a binding site in toll-like receptor 4 gene alters susceptibility to hepatocellular carcinoma in a Chinese Han population |
| Q37101911 | A miR-34a-SIRT6 axis in the squamous cell differentiation network |
| Q36861111 | A microRNA DNA methylation signature for human cancer metastasis |
| Q33828379 | A novel pathway of TEF regulation mediated by microRNA-125b contributes to the control of actin distribution and cell shape in fibroblasts |
| Q36016499 | A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion |
| Q52318631 | A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness. |
| Q37631219 | A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. |
| Q52562647 | A step-by-step microRNA guide to cancer development and metastasis. |
| Q42256808 | AAVPG: a vigilant vector where transgene expression is induced by p53. |
| Q38940296 | Aberrant methylation of miR-34b is associated with long-term shiftwork: a potential mechanism for increased breast cancer susceptibility |
| Q24339569 | Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress |
| Q38321235 | Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene. |
| Q34753903 | An Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma Chemoresistance |
| Q41222521 | An alternative microRNA-mediated post-transcriptional regulation of GADD45A by p53 in human non-small-cell lung cancer cells |
| Q35672216 | An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription |
| Q100512331 | Analysis of microRNA-34a expression profile and rs2666433 variant in colorectal cancer: a pilot study |
| Q50204710 | Animal Models to Study MicroRNA Function. |
| Q37743847 | Anomalous altered expressions of downstream gene-targets in TP53-miRNA pathways in head and neck cancer |
| Q38921935 | Anti-proliferative effects of polyphenols from pomegranate rind (Punica granatum L.) on EJ bladder cancer cells via regulation of p53/miR-34a axis |
| Q33827330 | Association between hsa-miR-34b/c rs4938723 T > C promoter polymorphism and cancer risk: a meta-analysis based on 6,036 cases and 6,204 controls |
| Q92042386 | Association of miR-34b/c rs4938723 and TP53 Arg72Pro Polymorphisms with Neuroblastoma Susceptibility: Evidence from Seven Centers |
| Q36179175 | Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma. |
| Q41791467 | Asymmetric division: An antitumor player? |
| Q51692717 | Benzo[a]pyrene induced p53-mediated cell cycle arrest, DNA repair, and apoptosis pathways in Chinese rare minnow (Gobiocypris rarus). |
| Q92977554 | Cancer cell reprogramming: a promising therapy converting malignancy to benignity |
| Q26744303 | Cellular Reprogramming Using Defined Factors and MicroRNAs |
| Q42119671 | CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress |
| Q34009053 | Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease |
| Q38906201 | Clinical Outcomes of TP53 Mutations in Cancers |
| Q35735278 | Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. |
| Q33720978 | Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs |
| Q34162527 | Constant p53 pathway inactivation in a large series of soft tissue sarcomas with complex genetics |
| Q33444270 | Correlation of expression profiles between microRNAs and mRNA targets using NCI-60 data |
| Q39547096 | CpG island methylation status of miRNAs in esophageal squamous cell carcinoma |
| Q38595057 | DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma |
| Q48114614 | DNA methylation regulated microRNAs in human cervical cancer. |
| Q37914075 | Delaying vascular aging with Chinese medicine: implications from an overview of the p53 and miR-34s family |
| Q38880958 | Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes |
| Q36241935 | Development and progression of colorectal neoplasia |
| Q34389645 | Dicer in immune cell development and function |
| Q33911218 | Dietary flaxseed modulates the miRNA profile in irradiated and non-irradiated murine lungs: a novel mechanism of tissue radioprotection by flaxseed. |
| Q37702713 | Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians |
| Q34705185 | Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome |
| Q37676245 | Dynamics of p53: A Master Decider of Cell Fate |
| Q39633529 | Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells |
| Q35999401 | EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours |
| Q39204898 | Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway |
| Q40949878 | Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer |
| Q35949238 | Emerging role of transcription factor-microRNA-target gene feed-forward loops in cancer |
| Q37272418 | Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. |
| Q37420152 | Epidermal growth factor receptor-regulated miR-125a-5p--a metastatic inhibitor of lung cancer |
| Q60960583 | Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study |
| Q37159843 | Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers |
| Q56271768 | Evolutionary Genomics of microRNAs and Their Relatives |
| Q35531846 | Exposure to diethylstilbestrol during pregnancy modulates microRNA expression profile in mothers and fetuses reflecting oncogenic and immunological changes |
| Q90264208 | Expression levels of miR-34-family microRNAs are associated with TP53 mutation status in head and neck squamous cell carcinoma |
| Q34372544 | Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice |
| Q34145858 | Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells |
| Q39608984 | Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas |
| Q28387391 | Gallium compound GaQ(3) -induced Ca(2+) signalling triggers p53-dependent and -independent apoptosis in cancer cells |
| Q33751085 | Gene and miRNA expression profiles of mouse Lewis lung carcinoma LLC1 cells following single or fractionated dose irradiation. |
| Q28237462 | Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis |
| Q53423040 | Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide. |
| Q38074617 | Genomics and epigenomics of colorectal cancer |
| Q26770487 | HPV-p53-miR-34a axis in HPV-associated cancers |
| Q36476953 | Hepatic mRNA, microRNA, and miR-34a-target responses in mice after 28 days exposure to doses of benzo(a)pyrene that elicit DNA damage and mutation |
| Q21183975 | High-throughput sequencing identifies STAT3 as the DNA-associated factor for p53-NF-kappaB-complex-dependent gene expression in human heart failure |
| Q59352758 | Homologous recombination is an intrinsic defense against antiviral RNA interference |
| Q39573183 | Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease |
| Q39565523 | Human EHMT2/G9a activates p53 through methylation-independent mechanism |
| Q37747546 | IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis. |
| Q37679965 | IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis |
| Q97646063 | Identification and Analysis of p53-Regulated Enhancers in Hepatic Carcinoma |
| Q36581556 | Identification of Molecular Targets for Predicting Colon Adenocarcinoma. |
| Q88733882 | Identification of differentially expressed microRNAs in Sahiwal (Bos indicus) breed of cattle during thermal stress |
| Q81003339 | Identification of genomic changes associated with cisplatin resistance in testicular germ cell tumor cell lines |
| Q21090874 | Identification of novel targets for miR-29a using miRNA proteomics |
| Q36054278 | Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA |
| Q35823226 | Inflammation regulates microRNA expression in cooperation with p53 and nitric oxide |
| Q43965867 | Inhibition of histone deacetylase causes emphysema |
| Q39232535 | Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease |
| Q64122393 | Innate extracellular vesicles from melanoma patients suppress β-catenin in tumor cells by miRNA-34a |
| Q35678071 | Integrated approaches to miRNAs target definition: time-series analysis in an osteosarcoma differentiative model. |
| Q35623093 | LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a |
| Q28555052 | LGR4 Is a Direct Target of MicroRNA-34a and Modulates the Proliferation and Migration of Retinal Pigment Epithelial ARPE-19 Cells |
| Q51416797 | Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma. |
| Q47736390 | Long Noncoding RNA uc.173 Promotes Renewal of the Intestinal Mucosa by Inducing Degradation of MicroRNA 195. |
| Q34676547 | Long intergenic noncoding RNAs: new links in cancer progression |
| Q55346192 | Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson's disease. |
| Q36469814 | MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer |
| Q38009700 | Mechanism(s) of alteration of micro RNA expressions in Huntington's disease and their possible contributions to the observed cellular and molecular dysfunctions in the disease |
| Q40355332 | Mechanisms of Impaired Neutrophil Migration by MicroRNAs in Myelodysplastic Syndromes |
| Q34039841 | Mechanisms of regulatory diversity within the p53 transcriptional network |
| Q34253391 | MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma. |
| Q39546216 | MiR-34a inhibits lymphatic metastasis potential of mouse hepatoma cells |
| Q64889318 | MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells. |
| Q47224057 | MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines |
| Q27320938 | MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma |
| Q37317570 | MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene |
| Q64230329 | MiR-34b-3p Represses the Multidrug-Chemoresistance of Bladder Cancer Cells by Regulating the CCND2 and P2RY1 Genes |
| Q92646260 | MiR-361-5p decreases the tumorigenicity of epithelial ovarian cancer cells by targeting at RPL22L1 and c-Met signaling |
| Q36565103 | MiR218 Modulates Wnt Signaling in Mouse Cardiac Stem Cells by Promoting Proliferation and Inhibiting Differentiation through a Positive Feedback Loop |
| Q34808577 | MiRNAs as Biomarkers for Management of Patients With Colorectal Cancer |
| Q35898407 | MicroRNA Involvement in Osteosarcoma |
| Q37962000 | MicroRNA dysregulation during chemical carcinogenesis |
| Q37802036 | MicroRNA functions in stress responses. |
| Q35814865 | MicroRNA library screening identifies growth-suppressive microRNAs that regulate genes involved in cell cycle progression and apoptosis. |
| Q33508232 | MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary |
| Q36906199 | MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers |
| Q33829462 | MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer |
| Q34571491 | MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways |
| Q35229253 | MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma |
| Q39173393 | MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer |
| Q34964080 | MicroRNA-196a is a putative diagnostic biomarker and therapeutic target for laryngeal cancer. |
| Q36212656 | MicroRNA-199a-5p is associated with hypoxia-inducible factor-1α expression in lungs from patients with COPD |
| Q39433270 | MicroRNA-21 versus microRNA-34: Lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact |
| Q92252739 | MicroRNA-34a Promotes Renal Fibrosis by Downregulation of Klotho in Tubular Epithelial Cells |
| Q39411948 | MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin |
| Q36746921 | MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether à go-go 1 expression |
| Q34211970 | MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo |
| Q42860070 | MicroRNA-34a is an important component of PRIMA-1-induced apoptotic network in human lung cancer cells |
| Q35874543 | MicroRNA-34a modulates cytoskeletal dynamics through regulating RhoA/Rac1 cross-talk in chondroblasts |
| Q53183370 | MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression. |
| Q38637987 | MicroRNA-34a suppresses colorectal cancer metastasis by regulating Notch signaling |
| Q41898973 | MicroRNA-34b has an oncogenic role in esophageal squamous cell carcinoma |
| Q39379374 | MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets. |
| Q34273664 | MicroRNA-449 and microRNA-34b/c function redundantly in murine testes by targeting E2F transcription factor-retinoblastoma protein (E2F-pRb) pathway. |
| Q35378724 | MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. |
| Q43096740 | MicroRNA-mediated regulation in biological systems with oscillatory behavior |
| Q24645163 | MicroRNA-mediated up-regulation of an alternatively polyadenylated variant of the mouse cytoplasmic {beta}-actin gene |
| Q36602853 | MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies |
| Q38250171 | MicroRNAs and photocarcinogenesis |
| Q37981157 | MicroRNAs as New Characters in the Plot between Epigenetics and Prostate Cancer |
| Q26774294 | MicroRNAs in Nonalcoholic Fatty Liver Disease |
| Q37632608 | MicroRNAs in colorectal cancer: translation of molecular biology into clinical application |
| Q39856376 | MicroRNAs in human embryonic and cancer stem cells |
| Q34675280 | MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. |
| Q38161836 | MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine. |
| Q38085906 | MicroRNAs in the ionizing radiation response and in radiotherapy |
| Q38035144 | MicroRNAs in the p53 network: micromanagement of tumour suppression |
| Q33942272 | MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. |
| Q36391961 | MicroRNAs, wild-type and mutant p53: more questions than answers |
| Q35673637 | MicroRNAs: short non-coding players in cancer chemoresistance. |
| Q58792269 | MicroRNA‑34b promotes proliferation, migration and invasion of Ewing's sarcoma cells by downregulating Notch1 |
| Q37679978 | Microenvironment-dependent cues trigger miRNA-regulated feedback loop to facilitate the EMT/MET switch. |
| Q33417186 | Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomy |
| Q24629083 | Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets |
| Q42792442 | Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis |
| Q35116008 | Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo. |
| Q38089839 | Molecular biomarkers for predicting chemotherapy response in lung cancer |
| Q34080682 | Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation |
| Q38204111 | Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks |
| Q54327684 | Mutational Status of CDKN2A and TP53 Genes in Laryngeal Squamous Cell Carcinoma. |
| Q38473066 | New therapeutic targets for cancer bone metastasis |
| Q41924654 | Noncoding RNA in drug resistant sarcoma |
| Q36571216 | Noncoding RNAs and Cancer. |
| Q37826349 | Novel Perspectives on p53 Function in Neural Stem Cells and Brain Tumors |
| Q93222983 | Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis |
| Q41834329 | Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene |
| Q33913135 | P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation |
| Q43632080 | Preparation of two types p53 recombinant adenovirus and quantitative exogenous expression of green fluorescence protein by flow cytometry |
| Q34215964 | Profiling of immune-related microRNA expression in human cord blood and adult peripheral blood cells upon proinflammatory stimulation |
| Q28652287 | Progress and bottleneck in induced pluripotency |
| Q36065663 | Proliferation and tumorigenesis of a murine sarcoma cell line in the absence of DICER1. |
| Q28541011 | Quantitative proteomic analysis of gene regulation by miR-34a and miR-34c |
| Q55190979 | Recombinant Adeno-Associated Virus-Mediated Delivery of MicroRNA-21-3p Lowers Hypertension. |
| Q33735297 | Reduced expression of circulating microRNA-218 in gastric cancer and correlation with tumor invasion and prognosis |
| Q39778710 | Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer |
| Q35188559 | Regulation of cyclin-dependent kinase 4 translation through CUG-binding protein 1 and microRNA-222 by polyamines |
| Q34009621 | Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease |
| Q39099572 | Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness |
| Q39032730 | Restoration of p53/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells |
| Q35593154 | Revealing the Molecular Portrait of Triple Negative Breast Tumors in an Understudied Population through Omics Analysis of Formalin-Fixed and Paraffin-Embedded Tissues. |
| Q34850281 | Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network |
| Q38216239 | Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapy. |
| Q33843352 | Role of p53 serine 46 in p53 target gene regulation |
| Q38346740 | Role of the AKT pathway in microRNA expression of human U251 glioblastoma cells |
| Q47211731 | Roles of microRNAs and RNA-Binding Proteins in the Regulation of Colorectal Cancer Stem Cells |
| Q36889773 | Rutin Attenuates Hepatotoxicity in High-Cholesterol-Diet-Fed Rats |
| Q39454272 | SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells |
| Q26829794 | SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer |
| Q59242704 | SNPs in MicroRNA Binding Sites in 3′-UTRs of RAAS Genes Influence Arterial Blood Pressure and Risk of Myocardial Infarction |
| Q53304624 | Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance |
| Q35768016 | Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients |
| Q35196062 | Serum interferon-related microRNAs as biomarkers to predict the response to interferon therapy in chronic hepatitis C genotype 4 |
| Q35852127 | Stress induces p38 MAPK-mediated phosphorylation and inhibition of Drosha-dependent cell survival |
| Q38821561 | Synergistic Effect and Molecular Mechanism of Homoharringtonine and Bortezomib on SKM-1 Cell Apoptosis |
| Q36921032 | Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a |
| Q90725046 | The Effect of Newly Synthesized Heterosteroids on miRNA34a, 98, and 214 Expression Levels in MCF-7 Breast Cancer Cells |
| Q38707758 | The MYC mRNA 3'-UTR couples RNA polymerase II function to glutamine and ribonucleotide levels. |
| Q28391426 | The Regulatory Role of MicroRNAs in EMT and Cancer |
| Q37687474 | The cell death machinery governed by the p53 tumor suppressor in response to DNA damage |
| Q24645732 | The first 30 years of p53: growing ever more complex |
| Q38148036 | The function, mechanisms, and role of the genes PTEN and TP53 and the effects of asbestos in the development of malignant mesothelioma: a review focused on the genes' molecular mechanisms |
| Q37415431 | The impact of microRNAs on colorectal cancer |
| Q36542788 | The impact of post-transcriptional regulation in the p53 network |
| Q30457564 | The miR-183/Taok1 target pair is implicated in cochlear responses to acoustic trauma |
| Q89666691 | The miR-34 family and its clinical significance in ovarian cancer |
| Q28245865 | The miR-34 family in cancer and apoptosis |
| Q38243969 | The miRNA network: micro-regulator of cell signaling in cancer |
| Q23909716 | The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells |
| Q37191373 | The microRNAs involved in human myeloid differentiation and myelogenous/myeloblastic leukemia |
| Q34143477 | The origins of cancer robustness and evolvability. |
| Q88959882 | The p53-signaling pathway and colorectal cancer: Interactions between downstream p53 target genes and miRNAs |
| Q38210767 | The p53/miR-34 axis in development and disease |
| Q38261312 | The p53/microRNA connection in gastrointestinal cancer |
| Q64237748 | The role and mechanisms of action of microRNAs in cancer drug resistance |
| Q37765520 | The role of MicroRNA in chemical carcinogenesis |
| Q38210729 | The role of vitamins and minerals in modulating the expression of microRNA. |
| Q33833892 | Tumor suppressor RASSF1A promoter: p53 binding and methylation |
| Q44608082 | Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. |
| Q37720029 | Tumor suppressor microRNA-34a inhibits cell proliferation by targeting Notch1 in renal cell carcinoma |
| Q34368649 | Unmet expectations: miR-34 plays no role in p53-mediated tumor suppression in vivo |
| Q49874934 | Values of miR-34a and miR-218 expression in the diagnosis of cervical cancer and the prediction of prognosis |
| Q35180856 | Wild-type p53 controls cell motility and invasion by dual regulation of MET expression |
| Q38771877 | miR clusters target cellular functional complexes by defining their degree of regulatory freedom |
| Q34522311 | miR-1226 targets expression of the mucin 1 oncoprotein and induces cell death. |
| Q24634704 | miR-145-mediated suppression of cell growth, invasion and metastasis |
| Q39043647 | miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress |
| Q37148515 | miR-195 competes with HuR to modulate stim1 mRNA stability and regulate cell migration |
| Q30585689 | miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110. |
| Q33901567 | miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner |
| Q30407836 | miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. |
| Q89241143 | miR-34a directly targets tRNAiMet precursors and affects cellular proliferation, cell cycle, and apoptosis |
| Q38713721 | miR-34a is downregulated in human osteosarcoma stem-like cells and promotes invasion, tumorigenic ability and self-renewal capacity |
| Q39465507 | miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy |
| Q37596868 | miR-34a regulates HDAC1 expression to affect the proliferation and apoptosis of hepatocellular carcinoma |
| Q35841308 | miR-34a screened by miRNA profiling negatively regulates Wnt/β-catenin signaling pathway in Aflatoxin B1 induced hepatotoxicity |
| Q53007110 | miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. |
| Q43794094 | miR-34c works downstream of p53 leading to dairy goat male germline stem-cell (mGSCs) apoptosis |
| Q34177681 | miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver |
| Q33703585 | microRNA, cell cycle, and human breast cancer |
| Q30409530 | microRNA-34a promotes DNA damage and mitotic catastrophe. |
| Q38668255 | microRNAs and Cardiovascular Remodeling |
| Q36189361 | p38/p53/miR-200a-3p feedback loop promotes oxidative stress-mediated liver cell death |
| Q38857307 | p53 Spreads out further: suppression of EMT and stemness by activating miR-200c expression |
| Q47955359 | p53 and miR-34a Feedback Promotes Lung Epithelial Injury and Pulmonary Fibrosis |
| Q34184384 | p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells |
| Q34973748 | p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. |
| Q42362115 | p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance |
| Q39716133 | p53- and p21-dependent premature APC/C-Cdh1 activation in G2 is part of the long-term response to genotoxic stress |
| Q35709920 | p53-Dependent induction of PVT1 and miR-1204. |
| Q33719450 | p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest |
Search more.